Zinzino AB (publ) Reported Preliminary Sales Results for the Month and Year to Date Ended August 2023. For the Month, sales markets increased by 14% and amounted to SEK 119.2 (104.3) million. Faun Pharma's external sales decreased by 1% and amounted to SEK 7.5 (7.6) million. Overall, the Group increased revenues by 13% to SEK 126.7 (111.9) million compared with the previous year.

For Accumulated revenue for January - August 2023 increased by 22 % to SEK 1078.8 (886.3) million.